Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer
Authors:
- 5 January 2017
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (5) , 1188-1194
Abstract
The administration of fluid irradiated with non-equilibrium atmospheric pressure plasma (NEAPP) has attracted much interest as a novel therapeutic method for cancer. The authors previously reported on the efficacy of plasma-activated medium (PAM) for treating cancer cell lines through the induction of apoptosis. In this study, the therapeutic effect of PAM was evaluated in vivo using a peritoneal metastasis mouse model.Keywords
This publication has 32 references indexed in Scilit:
- Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastasesJournal of Surgical Oncology, 2015
- Non-thermal plasma treatment altered gene expression profiling in non-small-cell lung cancer A549 cellsBMC Genomics, 2015
- Non‐thermal plasmas: novel preventive and curative therapy against melanomas?Experimental Dermatology, 2014
- Non-Thermal Atmospheric Pressure Plasma Preferentially Induces Apoptosis in p53-Mutated Cancer Cells by Activating ROS Stress-Response PathwaysPLOS ONE, 2014
- Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011Cancer Research and Treatment, 2014
- Cancer statistics, 2014CA: A Cancer Journal for Clinicians, 2014
- Disinfection of Ocular Cells and Tissues by Atmospheric-Pressure Cold PlasmaPLOS ONE, 2012
- Atmospheric-Pressure Plasma Jet Induces Apoptosis Involving Mitochondria via Generation of Free RadicalsPLOS ONE, 2011
- Applied Plasma MedicinePlasma Processes and Polymers, 2008
- Blood Coagulation and Living Tissue Sterilization by Floating-Electrode Dielectric Barrier Discharge in AirPlasma Chemistry and Plasma Processing, 2006